SV

Street Verdict

Analyst Scorecard

A record of what Marketsmith India Analysis said publicly, with the source. Not advice.

“Recommends buying Biocon in the ₹375–390 range, targeting ₹458 with a stop loss at ₹350, over a 2–3 month timeframe. The call is based on technical analysis and market direction methodology.”

Marketsmith India Analysis’s track record (trackable calls only): 322 graded calls · 95% CI 22–32%

BioconBullishCalled 15 Jan 2025Graded 14 Feb 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

Entry zone: ₹375–₹390. The call starts at the first close that comes into it.

Target ₹458, stop ₹350, as stated.

Window: 90 days, the time frame the call states ("2–3 month").

The stop ₹350 was reached on a close before the target ₹458. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹388.05 on 2025-01-22 (stated entry ₹375–390 zone, ZONE entry, filled); stop ₹350 breached at close ₹349.35 on 2025-02-14. Window 90 days — rule H1: the quote states "2–3 month".

Tracking Biocon since this call

1-year tracking window
Read the original articleSee Marketsmith India Analysis’s full track record